# Feasibility Study of Metformin Therapy in ADPKD

> **NCT02903511** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 56 (actual)

## Conditions studied

- Polycystic Kidney, Autosomal Dominant

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02903511
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2020-08-17
- **Final completion:** 2020-08-17
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02903511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02903511, "Feasibility Study of Metformin Therapy in ADPKD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02903511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*